Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis

Figure 5

GSEA pathways enriched in samples with high MAD2L1 expression: (a) DNA repair; (b) G2M checkpoint; (c) E2F targets; (d) MYC targets; (e) glycolysis; (d) unfold protein response; (g) P53 pathway; (h) PI3K/AKT/TOR pathway; (i) wnt-β-catenin pathway. ES: enrichment score; NES: normalized enrichment score; FDR: false discovery rate.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)